Bemidji Chamber Ambassadors welcomed Clinical Director and Occupational Therapist Kayla Borszich of Little Miracles, Inc. on ...

A recent study published in the Journal of the American Dental Association found that Tirzepatide presented a novel strategy ...

Panelists discuss how intrathecal delivery of onasemnogene abeparvovec in the STEER study demonstrates statistically significant motor function improvements in older patients with SMA (ages 2-18 years ...

Ventyx Biosciences has reported encouraging top-line outcomes from its single-centre Phase IIa trial of the central nervous system (CNS)-penetrant NLRP3 inhibitor, VTX3232, in individuals with ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Spinal Muscular Atrophy treatment is evolving fast, with gene therapy, oral drugs, and next-gen muscle enhancers offering new hope and long-term outcomes. With each breakthrough in SMA treatment, we ...

Scientists discover that dental pulp stem cells from wisdom teeth could regenerate neurons and bones and offer treatments for ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

R09b, for the treatment of Primary Parkinson’s Disease (PD), has received Fast Track Designation (FTD) from the U.S. Food and ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge therapeutic treatment for advanced Parkinson’s disease, making it the first ...